Your email has been successfully added to our mailing list.

×
0 0.000565872730078645 -0.0414630382221308 -0.0431606564123669 -0.033180719172797 -0.0122948711353465 -0.0225834662276866 -0.0122948711353465
Stock impact report

VolitionRx up 14% on encouraging data on Nu.Q in prostate cancer [Seeking Alpha]

VolitionRX Limited (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
Company Research Source: Seeking Alpha
VolitionRx up 14% on encouraging data on Nu.Q in prostate cancer Show less Read more
Impact Snapshot
Event Time:
VNRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VNRX alerts
Opt-in for
VNRX alerts

from News Quantified
Opt-in for
VNRX alerts

from News Quantified